These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
262 related items for PubMed ID: 1175125
1. A comparison of nitrogen mustard, vincristine, procarbazine, and prednisone (MOPP) vs. nitrogen mustard in advanced Hodgkin's disease. Huguley CM, Durant JR, Moores RR, Chan YK, Dorfman RF, Johnson L. Cancer; 1975 Oct; 36(4):1227-40. PubMed ID: 1175125 [Abstract] [Full Text] [Related]
2. Combination chemotherapy for stage IV Hodgkin's disease (Report no 14). Goldman JM. Clin Radiol; 1981 Sep; 32(5):531-6. PubMed ID: 6168426 [Abstract] [Full Text] [Related]
3. Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. Duggan DB, Petroni GR, Johnson JL, Glick JH, Fisher RI, Connors JM, Canellos GP, Peterson BA. J Clin Oncol; 2003 Feb 15; 21(4):607-14. PubMed ID: 12586796 [Abstract] [Full Text] [Related]
4. Value of prednisone in combination chemotherapy of stage IV Hodgkin's disease. Report from the British National Lymphoma Investigation. Br Med J; 1975 Aug 16; 3(5980):413-4. PubMed ID: 1098721 [Abstract] [Full Text] [Related]
5. Prednisone in MOPP chemotherapy for Hodgkin's disease. Jacobs C, Portlock CS, Rosenberg SA. Br Med J; 1976 Dec 18; 2(6050):1469-71. PubMed ID: 1000259 [Abstract] [Full Text] [Related]
6. Doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) salvage of mechlorethamine, vincristine, prednisone, and procarbazine (MOPP)-resistant advanced Hodgkin's disease. Piga A, Ambrosetti A, Todeschini G, Cetto G, Perona G, Cellerino R. Cancer Treat Rep; 1984 Dec 18; 68(7-8):947-51. PubMed ID: 6204754 [Abstract] [Full Text] [Related]
7. Treatment of advanced Hodgkin's disease with adriamycin, bleomycin, vinblastine, and imidazole carboxamide (ABVD) after failure of MOPP therapy. Krikorian JG, Portlock CS, Rosenberg SA. Cancer; 1978 Jun 18; 41(6):2107-11. PubMed ID: 77716 [Abstract] [Full Text] [Related]
8. Can MOPP be replaced in the treatment of advanced Hodgkin's disease? Canellos GP. Semin Oncol; 1990 Feb 18; 17(1 Suppl 2):2-6. PubMed ID: 1689509 [Abstract] [Full Text] [Related]
9. [Early results of combined treatment in Hodgkin's disease with nitrogen mustard, vincristine, Natulan and prednisone (MOPP treatment)]. Zelechowska JA, Madej G, Piemkowska F. Nowotwory; 1976 Feb 18; 26(3):163-70. PubMed ID: 980801 [No Abstract] [Full Text] [Related]
10. [Results of combined chemotherapy (MOPP) in the treatment of patients with generalized Hodgkin's disease]. Aghai E, Kende G, Many A, Ramot B. Harefuah; 1974 Apr 01; 86(7):348-51. PubMed ID: 4846045 [No Abstract] [Full Text] [Related]
11. Combinaed chemotherapy with cyclophosphamide, vinblastine, procarbazine, and prednisone (CVPP) for patients with advanced Hodgkin's disease. An alternative program to MOPP. Bloomfield CD, Weiss RB, Fortuny I, Vosika G, Kennedy BJ. Cancer; 1976 Jul 01; 38(1):42-8. PubMed ID: 947533 [Abstract] [Full Text] [Related]
12. [Post-MOPP chemotherapy of Hodgkin's disease (author's transl)]. Osieka R, Bruntsch U, Gallmeier WM, Seeber S, Schmidt CG. Dtsch Med Wochenschr; 1976 Aug 06; 101(32):1177-82. PubMed ID: 59661 [Abstract] [Full Text] [Related]
15. Combined cyclophosphamide vincristine, procarbazine, and prednisone (COPP) therapy of malignant lymphoma. Evaluation of 190 patients. Morgenfeld MC, Pavlovsky A, Suarez A, Somoza N, Pavlovsky S, Palau M, Barros CA. Cancer; 1975 Oct 06; 36(4):1241-9. PubMed ID: 1100220 [Abstract] [Full Text] [Related]
17. MOPP chemotherapy for advanced Hodgkin's disease. Prognostic factors in 81 patients. Moore MR, Jones SE, Bull JM, William LA, Rosenberg SA. Cancer; 1973 Jul 06; 32(1):52-60. PubMed ID: 4716784 [No Abstract] [Full Text] [Related]